Alaunos Therapeutics TCRT
NASDAQ TCRT
$3.03 +0.06 (+2.02%)
As of: Oct 21, 2026 · 10:12 AM EDT

Alaunos Therapeutics (TCRT) Non-Current Debt (2021 - 2022)

Updated

Alaunos Therapeutics' Non-Current Debt came in at -$5.41 million for FY2018.

Analysis

Alaunos Therapeutics (TCRT) Non-Current Debt (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn 62.48 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn 60.50 Bn
10 Alaunos Therapeutics 7.35 Mn 3.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4.47 Mn
Mar 31, 2022 10.32 Mn
Dec 31, 2021 16.25 Mn
Sep 30, 2021 12.17 Mn
API Access

Alaunos Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TCRT&period=max&api_key=YOUR_API_KEY